IVHEM
Meeting category
Date(s)
7 Dec 2018 - 8 Dec 2018
Location
Amsterdam, Netherlands
CME credits
Organizer
Titanium Level Support
Sponsor logos
Gilead logo

International Viral Hepatitis Elimination Meeting (IVHEM) 2018

Related Enduring Materials

Enduring Materials

Day 1 - Friday, 7 December 2018

- 13:00
13:00 CEST
Welcome and opening
Opening Session -
Chairs
Jordan Feld
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease, Canada
Margaret Hellard
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
13:05 CEST
Keynote: The elimination movement
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
13:25 CEST
WHO - update on the performance indicator
Yvan Hutin
Yvan Hutin, MD, PhD
World Health Organization, Switzerland
13:45 CEST
The economic barriers preventing elimination – the importance of an investment
Session 1: Monitoring: Finding the missing millions - HBV -
Chair
John Ward
John Ward, MD
Centers for Disease Control and Prevention
Lina Nerlander
Lina Nerlander
European Centre for Disease Prevention and Control, Sweden
14:30 CEST
Introduction
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
14:45 CEST
Best practice talk - Myanmar
Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP
Ministry of Health, Myanmar; Ni Ni Diagnostics and Health Care Centre
15:00 CEST
Best practice talk - Rwanda
Constance Mukabatsinda
Constance Mukabatsinda, MD
Kigali University, Rwanda
15:15 CEST
Discussion
Session 2: Monitoring: Finding the missing millions - HCV -
Chair
Michael Ninburg
Michael Ninburg
Hepatitis Education Project
Yvan Hutin
Yvan Hutin, MD, PhD
World Health Organization, Switzerland
15:45 CEST
Introduction by Michael Ninburg
16:00 CEST
Best practice talk - Egypt
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
16:15 CEST
Best practice talk - France
Sylvie Deuffic-Burban
Sylvie Deuffic-Burban, PhD
Inserm, France
16:30 CEST
Discussion
Session 3: Linkage to Care -
Chair
Lesi Olufunmilayo
Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
University of Lagos, Nigeria
Charles Boucher
Charles Boucher, MD, PhD
Erasmus Medical Center, the Netherlands
17:15 CEST
Introduction
Olufunmilayo Lesi, MD, MBA, FWACP, FMCP
World Health Organization, Switzerland
17:30 CEST
Best practice talk - The Netherlands
Marc van der Valk
Marc van der Valk, MD, PhD
AMC Amsterdam, The Netherlands
17:45 CEST
Best practice talk - Australia
Alisa Pedrana
Alisa Pedrana, PhD
Burnet Institute, Australia
18:00 CEST
Discussion

Day 2 - Saturday, 8 December 2018

Session 4: Strategic information -
Chair
Jordan Feld
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease
Hatzakis, Angelos
Angelos Hatzakis, MD, PhD, MSc
Athens University Medical School, Greece
08:30 CEST
Introduction
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease, Canada
08:45 CEST
Greece - ARISTOTLE HCV: A fast-track intervention to seek-test-link-treat PWIDs in Athens
Vana Sypsa, PhD
National and Kapodistrian University of Athens, Greece
09:00 CEST
Best practice talk - Iceland
Sigurdur Olafsson
Sigurdur Olafsson, MD, FACP
Landspitali University Hospital Hringbraut, Iceland
09:15 CEST
Discussion
09:45 CEST
Oral abstract presentations
Successful cascade of care and cure HCV in more than 2000 drugs users: how increase HCV treatment rate in drug users by nurse outreach care, since screening to treatment
Andre Jean Remy
Integrating Hepatitis C Virus Screening and Linkage to Care of Baby Boomers at Community Hospital Emergency Department
Angelica Mercado
Estimating the Impact and Costs of Scaling-Up Screening and Treatment for Hepatitis C Virus Elimination in Pakistan
Aaron Lim
Monitoring viral hepatitis elimination – generating reliable estimates of hepatitis C prevalence
Ida Sperle-Heupel
Hepatitis C care cascade in the country of Georgia: monitoring progress towards elimination
Tengiz Tsertsvadze
Disproportions in the HCV incidence between Centers Addictions and Harm Reduction Unit
Jorge Valencia La Rosa
Integrated testing and integrated diagnostic platforms of Hepatitis B and C with HIV and TB in Rwanda
Jean Damascene Makuza
HCV, HBV and HIV infection and linkage to care in migrants: The Immigrant Take Care Advocacy (I.Ta.C.A.) experience in Palermo
Marco Tutone
Session 5: Integrated approaches -
Chair
Jeffrey Lazarus
Jeffrey Lazarus, PhD
University of Barcelona, Spain
Manal El-Sayed
Manal El-Sayed, MD
Ain Shams University, Cairo, Egypt
11:30 CEST
Introduction
Jeffrey V. Lazarus, PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
11:45 CEST
Best practice talk - Georgia
Amiran Gamkrelidze
Amiran Gamkrelidze, MD, PhD
National Center for Disease Control and Public Health, Georgia
12:00 CEST
Best practice talk - USA
Timothy Morgan
Timothy Morgan, MD
Department of Veterans Affairs, USA
12:15 CEST
Discussion
12:45 CEST
Closing remarks
Overview
Welcome

We are pleased to look back on a very succesful 5th edition of the International Viral Hepatitis Elimination Meeting (IVHEM), held in Amsterdam, the Netherlands on 7-8 December 2018.

More than 100 delegates attended the meeting and the Organizing committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! In particular we would like to thank our sponsor, GILEAD. Without their financial contribution this meeting would not have been made possible.

We look forward to seeing you again at the next edition of the International Viral Hepatitis Elimination Meeting. 

The Organizing committee

Support
Titanium Level
Endorsers

The International Viral Hepatitis Elimination Meeting (IVHEM) 2019 is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this meeting.

Language